Analystreport

Integra lifesciences (NASDAQ: IART) was given a new $58.00 price target on by analysts at Oppenheimer Holdings Inc.. They now have a "buy" rating on the stock.

Integra LifeSciences Holdings Corporation  (IART) 
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.integralife.com